GlycoMimetics stockholders approve increase in authorized shares to 150M and officer exculpation amendment

At the 2024 Annual Meeting of Stockholders held on May 1, 2024 (the “ Annual Meeting ”), the stockholders of GlycoMimetics, Inc. (the “ Company ”) approved (i) an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Restated Certificate ”) to increase the authorized number of shares of the Company’s common stock from 100,000,000 to 150,000,000 shares and (ii) an amendment to the Restated Certificate to include a provision eliminating or limiting monetary liability for specified corporate officers for breach of fiduciary duty in certain actions as permitted by the General Corporation Law of the State of Delaware.

At the 2024 Annual Meeting of Stockholders held on May 1, 2024 (the “ Annual Meeting ”), the stockholders of GlycoMimetics, Inc. (the “ Company ”) approved (i) an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Restated Certificate ”) to increase the authorized number of shares of the Company’s common stock from 100,000,000 to 150,000,000 shares and (ii) an amendment to the Restated Certificate to include a provision eliminating or limiting monetary liability for specified corporate officers for breach of fiduciary duty in certain actions as permitted by the General Corporation Law of the State of Delaware.

Proposal No. 3: Stockholders approved, on an advisory basis, the executive compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The votes were cast as follows: ​ 5,2 Votes For Votes Against Abstentions Approval, on an advisory basis, of the executive compensation of the named executive officers. 35,292,808 ​ 1,881,276 ​ 75,670 ​ Broker Non-Votes: 13,231,353 2 ​ ​

Proposal No. 5: Stockholders approved an amendment to the Restated Certificate to reflect new Delaware law provisions regarding officer exculpation. The votes were cast as follows: ​ 6,172,8 Votes For Votes Against Abstentions Amend Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation. 36,172,684 ​ 1,045,748 ​ 31,322 ​ Broker Non-Votes: 13,231,353 ​

Proposal No. 2 : Stockholders ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2024. The votes were cast as follows: ​ Votes For Votes Against Abstentions Ratification of appointment of Ernst & Young LLP 50,319,444 ​ 40,448 ​ 121,215 ​ ​ ​

Proposal No. 4: Stockholders approved an amendment to the Company’s Amended and Restated Certificate of Incorporation (the “ Restated Certificate ”) to increase the authorized number of shares of common stock from 100,000,000 shares to 150,000,000 shares. The votes were cast as follows: ​ Votes For Votes Against Abstentions Amend Certificate of Incorporation to increase authorized shares of common stock from 100,000,000 to 150,000,000. 49,332,242 ​ 1,014,592 ​ 134,273 ​ Broker Non-Votes: 0 ​

Proposal No. 1 : Stockholders elected two nominees to serve as directors until the 2027 annual meeting of stockholders and until their respective successors are elected and qualified. The votes were cast as follows: ​ Name Votes For Votes Withheld Daniel Junius 34,583,868 ​ 2,665,886 Rachel King ​ 37,007,330 ​ 242,424 ​ ​ Broker Non-Votes: 13,231,353 ​